ArticleMedicina (Kaunas, Lithuania)2026

BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility.

Ozlem Candan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.